loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Lamivudine

    Menu

    Lamivudine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 106Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 210807 / DOSAGE - TABLET;ORAL - 100MG;300MG;300MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    doravirine(UNII: 913P6LK81M)
    (doravirine - UNII:913P6LK81M)     		doravirine100mg | 100mg
    lamivudine(UNII: 2T8Q726O95)
    (lamivudine - UNII:2T8Q726O95)     		lamivudine300mg | 300mg
    tenofovir disoproxil fumarate(UNII: OTT9J7900I)
    (tenofovir anhydrous - UNII:W4HFE001U5)     		tenofovir disoproxil fumarate300mg | 300mg

    Inactive Ingredients

    Ingredient Name
    Merck Sharp & Dohme LLC
    carnauba wax(R12CBM0EIZ)
    croscarmellose sodium(M28OL1HH48)
    ferric oxide yellow(EX438O2MRT)
    hypromellose acetate succinate 06081224 (3 MM2/S)(6N003M473W)
    hypromellose, unspecified(3NXW29V3WO)
    lactose monohydrate(EWQ57Q8I5X)
    magnesium stearate(70097M6I30)
    microcrystalline cellulose(OP1R32D61U)
    silicon dioxide(ETJ7Z6XBU4)
    sodium stearyl fumarate(7CV7WJK4UI)
    titanium dioxide(15FIX9V2JP)
    triacetin(XHX3C3X673)